Neuroinflammatory processes are a central feature of Alzheimer's disease (AD) in which
microglia are over-activated, resulting in the increased production of pro-inflammatory …

Osteoporosis and Alzheimer's disease (AD) are both degenerative diseases. Osteoporosis
often proceeds cognitive deficits, and multiple studies have revealed common triggers that …

Background: Neuroinflammation plays an important role in Alzheimer's disease (AD). During
this process, activated microglia release pro-inflammatory cytokines such as interleukin (IL) …

Abstract “Neurodegenerative disorder” is an umbrella term for a group of fatal progressive
neurological illnesses characterized by neuronal loss and inflammation. Interleukin-6 (IL-6) …

Background: Pharmacogenetic effects of statins on clinical changes in Alzheimer's disease
(AD) could be mediated by epistatic interactions among relevant genetic variants involved in …

Objectives Recently, several meta-analyses have reported an association between
interleukin (IL) gene polymorphisms and the risk of Alzheimer's disease (AD). Several further …

Acne vulgaris (AV) ranks among the common chronic inflammatory disorders that impact the
sebaceous components of hair follicles. Acne vulgaris is characterised by cardinal …

We investigated the relationships between single nucleotide polymorphisms (SNPs) of the
interleukin (IL)-6 gene 174 G> C (rs1800795), 572 G> C (rs1800796), and 597 G/A …

Background: Alzheimer's disease (AD) is a neurodegenerative disorder characterized by
extracellular amyloid plaque and neurofibrillary tangles in the brain. Studies have shown …

Drug discovery for Alzheimer's Disease (AD) is channeled towards unravelling key disease
specific drug targets/genes to predict promising therapeutic candidates. Though enormous …